TOKUYAMA CORP/ADR (OTCMKTS:TKYMY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The brokerage presently has a $13.00 price objective on the stock. Zacks Investment Research‘s price target indicates a potential upside of 12.26% from the company’s previous close.

According to Zacks, “Tokuyama Corporation manufactures and sells chemicals, specialty products, cement and functional materials. Chemicals segment offers soda ash, caustic soda, calcium chloride, silicate soda, vinyl chloride resin, propylene oxide, isopropyl alcohol and methylene chloride. Specialty Products segment offers multicrystalline silicon, wet silica, metal cleaning chemicals, high-purity chemicals for electronic industry, environmental-related equipment and others. Cement segment offers portland cement, ready-mixed concrete and cementitious solidified materials. Life Amenity segment offers polypropylene film, resin sashes and others. Tokuyama Corporation is based in Chiyoda-Ku, Japan. “

OTCMKTS:TKYMY remained flat at $$11.58 on Wednesday. The business has a fifty day moving average price of $10.76 and a 200-day moving average price of $12.01. The company has a market capitalization of $1.61 billion, a PE ratio of 6.00 and a beta of 0.21. TOKUYAMA CORP/ADR has a 52-week low of $10.15 and a 52-week high of $13.24.

About TOKUYAMA CORP/ADR

Tokuyama Corporation produces and sells various chemical products in Japan. The company operates in four segments: Chemicals, Specialty Products, Cement, and Life & Amenity. The Chemicals segment offers soda ash, calcium chloride, sodium silicate, caustic soda, vinyl chloride monomer, propylene oxide, chlorinated solvents, isopropyl alcohol, and polyvinyl chloride.

Recommended Story: Dollar Cost Averaging

Get a free copy of the Zacks research report on TOKUYAMA CORP/ADR (TKYMY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for TOKUYAMA CORP/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TOKUYAMA CORP/ADR and related companies with MarketBeat.com's FREE daily email newsletter.